Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

ConclusionsThese results suggest that total, aggregated and phosphorylated α-Syn levels are altered in PD erythrocytes and peripheral erythrocytic α-Syn is a potential PD biomarker that needs further validation.

Source: Translational Neurodegeneration - May 14, 2019 Category: Neurology Source Type: research